ASK PHARM(SZ:002755) Xin Lang Cai Jing·2025-11-17 02:25Group 1 - The core point of the news is that Aosaikang's stock price dropped by 5.18% to 18.67 CNY per share, with a trading volume of 210 million CNY and a turnover rate of 1.19%, resulting in a total market capitalization of 17.329 billion CNY [1] - Aosaikang Pharmaceutical Co., Ltd. is located in Jiangning Science Park, Nanjing, Jiangsu Province, and was established on December 24, 1996. The company was listed on May 15, 2015, and its main business involves the research, production, and sales of digestive, anti-tumor, and other pharmaceuticals [1] - The revenue composition of Aosaikang's main business includes: anti-tumor drugs 38.28%, anti-infection drugs 24.74%, chronic disease drugs 21.65%, digestive drugs 12.33%, and others 3.00% [1] Group 2 - Among Aosaikang's top ten circulating shareholders, a fund under E Fund ranks as a significant shareholder. The E Fund Healthcare Industry Mixed A (110023) increased its holdings by 262,000 shares in the third quarter, holding a total of 5.7132 million shares, which accounts for 0.62% of the circulating shares [2] - The E Fund Healthcare Industry Mixed A (110023) was established on January 28, 2011, with a latest scale of 3.802 billion CNY. Year-to-date returns are 40.28%, ranking 1705 out of 8213 in its category; the one-year return is 31.56%, ranking 2111 out of 8130; and since inception, the return is 327.3% [2]